✨ Your Portfolio is fetched and updated from zerodha.
Nano Pharmaceuticals

Amkay Products Ltd.

AMKAY

Market Cap
₹45 Cr.
P/E
19.61

Amkay Products Ltd.

Key Ratios

Edit Ratio's
Market cap
Market cap
45.00 Cr
PE
PE
19.61
Prom Holding
Prom Holding
73.44 %
ROE (%)
ROE (%)
13.87
ROCE (%)
ROCE (%)
18.50
Div Yield (%)
Div Yield (%)
-
Sales
Sales
42.03 Cr
OPM (%)
OPM (%)
9.15 %
Debt to Equity
Debt to Equity
0.11
Institutions
Institutions
-
Individual < 2 lac
Individual < 2 lac
13.07 %
No. of Shareholders
No. of Shareholders
394
View more
Edit Ratio's

About

Amkay Products, established in 2007, specializes in manufacturing and marketing a wide range o… Read more
Low
39
52W Range
High
82
  • Amkay Products
  • KMS Medisurgi
  • Shree Pacetronix

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statement

New
Edit rows

Forensics

8 Yes

Positive for this company

2 Neutral

Neutral for this company

5 No

Negative for this company

2 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Peer Comparison

FAQs on Amkay Products Ltd. Business

Amkay Products was incorporated on October 25, 2007. It manufactures, assembles &amp; markets a comprehensive portfolio of medical devices, disposables and other Healthcare Products like Face Mask, Alcohol Swabs, Lancet Needles, Nebulizer, Pulse Oximeter, surgeon cap etc. used by healthcare centers, hospitals/clinics, nursing homes etc. widely spread across India. In addition, it is also engaged in branding and marketing of some of the products like Diapers, Plastic Gloves, Suction Machines etc.

Amkay Products major competitors are KMS Medisurgi, Shree Pacetronix, Kretto Syscon, GKB Ophthalmics, Centenial Surg. Sut., Galaxy Medicare, Transpact Enterprise.
Market Cap of Amkay Products is ₹45 Crs.
While the median market cap of its peers are ₹32 Crs.

Amkay Products seems to be less financially stable compared to its competitors.
Altman Z score of Amkay Products is 6.67 and is ranked 4 out of its 8 competitors.

View FAQ's On Shareprice

Company Filing

2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY26 FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary

Discussions & Analysis

Pharmaceuticals
GLP-1: The Drug Redefining Diabetes, Obesity, and Pharma’s Future - Perpetuity
Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC
Generic Opportunity for Indian Pharma Companies - Anish Moonka
Nutraceuticals- Industry Overview - Value Educator
Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
Pharma Compliance In-Depth - Amit Rajan
Deep Dive into Pharma Sector - Omkara Capital
How The Pharma Industry Works - PPFAS
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material